RK, L., F, E., SV, H., & MD, B. (2026). TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications. Handbook of experimental pharmacology. https://doi.org/10.1007/164_2026_821
Chicago Style (17th ed.) CitationRK, Lenham, Elgammal F, Harding SV, and Berry MD. "TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications." Handbook of Experimental Pharmacology 2026. https://doi.org/10.1007/164_2026_821.
MLA (9th ed.) CitationRK, Lenham, et al. "TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications." Handbook of Experimental Pharmacology, 2026, https://doi.org/10.1007/164_2026_821.
Warning: These citations may not always be 100% accurate.